Skip to content
Developing novel methods to study drug safety and effectiveness [email protected] McGill University Health Centre
Canaim
  • Home
  • About CAN-AIM
  • Projects
    • COVID-19 Initiatives
    • Research Methodology
    • Responses to Specific DSEN Queries
    • Capacity Building
    • CAN-AIM Demonstration Project
  • Research & Resources
    • Research Papers
    • Presentations
    • Videos
    • Media
  • Who We Are
  • News
  • Contact Us
Responses to Specific DSEN Queries

Hydrochlorothiazide and risk of melanoma and non-melanoma skin cancer

Non-melanoma skin cancer (NMSC) is thought to be the most commonly diagnosed cancer in Canadians. There are two main types of NMSC, including basal cell

Read More »
July 15, 2020 No Comments

Active Surveillance & Canadian multi-province Cohorts of Pregnant Women and Children

Query 19-03: Active Surveillance & Canadian multi-province Cohorts of Pregnant Women and Children. This research is funded by the Drug Safety and Effectiveness Network (DSEN)

Read More »
July 15, 2020 No Comments

Predictors of chronic opioid use in non-cancer community-dwelling patients

High consumption rates of prescription opioids in Canada raised the need to understand factors associated with chronic use to counteract opioid-related harms (addiction, misuse, abuse

Read More »
April 24, 2019 No Comments

Comparative effectiveness and safety of biosimilars and legacy drugs

In Canada, and worldwide, there is a need for updated, independent, real-world comparative effectiveness and safety data related to biologic drugs including biosimilar drugs.  Our

Read More »
July 23, 2018 No Comments

Low dose fluconazole and adverse pregnancy outcomes

Query 16-09: Low dose fluconazole and adverse pregnancy outcomes. This research was funded by the Drug Safety and Effectiveness Network (DSEN) and conducted by the

Read More »
July 23, 2018 No Comments

Ondansetron and fetal abnormality

Query 16-08: Ondansetron use in pregnancy and risk of fetal abnormality. This research was funded by the Drug Safety and Effectiveness Network (DSEN) and conducted

Read More »
August 9, 2017 No Comments
« Previous Page1 Page2 Page3 Page4 Page5 Next »

Recently Added

  • DSECT/DSEN Seminar Series Invitation
  • Prescription patterns of ranitidine, nizatidine, famotidine, and cimetidine in Canada
  • Presentation on the Drug Safety and Effectiveness Network (DSEN) Methods and Applications Group for Indirect Comparisons (MAGIC) Rapid Reviews and COVID-19

Archives

  • May 2021
  • April 2021
  • November 2020
  • October 2020
  • July 2020
  • May 2019
  • April 2019
  • July 2018
  • August 2017
  • August 2016
  • May 2016
  • May 2014
MEMBER'S UNIVERSITIES
© 2023 Copyrights CAN-AIM | All rights Reserved ~ login